In acute respiratory distress syndrome (ARDS) caused by bacterial pneumonia, the AQP5 -1364A/C promoter polymorphism’s C-allele was linked to reduced pulmonary inflammation and improved 30-day survival rates, offering potential insights for characterizing and treating ARDS on an individualized basis. The gene discussed is AQP5; the disease is acute respiratory distress syndrome.